- Home
- NWTN vs KOD Comparison
NWTN vs KOD Comparison
Compare NWTN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWTN
- KOD
- Stock Information
- Founded
- NWTN 2016
- KOD 2009
- Country
- NWTN United Arab Emirates
- KOD United States
- Employees
- NWTN N/A
- KOD N/A
- Industry
- NWTN Auto Manufacturing
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NWTN Consumer Discretionary
- KOD Health Care
- Exchange
- NWTN Nasdaq
- KOD Nasdaq
- Market Cap
- NWTN 100.7M
- KOD 115.0M
- IPO Year
- NWTN N/A
- KOD 2018
- Fundamental
- Price
- NWTN $0.61
- KOD $3.90
- Analyst Decision
- NWTN
- KOD Hold
- Analyst Count
- NWTN 0
- KOD 3
- Target Price
- NWTN N/A
- KOD $9.00
- AVG Volume (30 Days)
- NWTN 239.5K
- KOD 469.8K
- Earning Date
- NWTN 01-01-0001
- KOD 05-19-2025
- Dividend Yield
- NWTN N/A
- KOD N/A
- EPS Growth
- NWTN N/A
- KOD N/A
- EPS
- NWTN N/A
- KOD N/A
- Revenue
- NWTN $37,333,000.00
- KOD N/A
- Revenue This Year
- NWTN N/A
- KOD N/A
- Revenue Next Year
- NWTN N/A
- KOD N/A
- P/E Ratio
- NWTN N/A
- KOD N/A
- Revenue Growth
- NWTN N/A
- KOD N/A
- 52 Week Low
- NWTN $0.30
- KOD $1.92
- 52 Week High
- NWTN $5.00
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- NWTN 75.98
- KOD 55.59
- Support Level
- NWTN $0.38
- KOD $3.66
- Resistance Level
- NWTN $0.42
- KOD $4.20
- Average True Range (ATR)
- NWTN 0.08
- KOD 0.47
- MACD
- NWTN 0.04
- KOD 0.02
- Stochastic Oscillator
- NWTN 78.98
- KOD 40.98
About NWTN NWTN Inc.
NWTN Inc is a pioneering smart electric vehicle company which aims to integrate avant-garde design, life-style personalization, IoT connectivity, and autonomous driving technology into a passenger-centric green premium mobility solution to the world.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.